These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18839274)

  • 1. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
    Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
    Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
    Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
    Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.
    Bairey O; Kirgner I; Yakobi M; Hamdan A; Ben-Ari Z; Shaklai M
    Am J Hematol; 2002 Apr; 69(4):281-4. PubMed ID: 11921023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A; Ishii E; Nagatoshi Y; Eguchi H; Koga H; Yanai F; Inada H; Nibu K; Tamai Y; Akiyoshi K; Nakayama H; Hara T; Take H; Miyazaki S; Okamura J
    Int J Hematol; 2001 Apr; 73(3):369-77. PubMed ID: 11345205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.
    Tang W; Ziring D; Gershman G; French S
    Exp Mol Pathol; 2003 Dec; 75(3):201-9. PubMed ID: 14611811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the oral health of children during treatment for acute lymphoblastic leukaemia.
    O'Sullivan EA; Duggal MS; Bailey CC
    Int J Paediatr Dent; 1994 Mar; 4(1):31-4. PubMed ID: 7748846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Yamamoto M; Hori T; Igarashi K; Iesato K; Saito M; Miyanishi K; Kikuchi N; Fujita H; Tsutsumi H
    Int J Hematol; 2018 Apr; 107(4):390-391. PubMed ID: 29181701
    [No Abstract]   [Full Text] [Related]  

  • 10. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Soslow RA; Davis RE; Warnke RA; Cleary ML; Kamel OW
    Blood; 1996 Jun; 87(12):5207-12. PubMed ID: 8652834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Campana D; Pui CH
    Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
    [No Abstract]   [Full Text] [Related]  

  • 13. Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
    Sahoo RK; Sharma A
    Pediatr Blood Cancer; 2011 Oct; 57(4):700. PubMed ID: 21656901
    [No Abstract]   [Full Text] [Related]  

  • 14. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
    Saito T; Seo S; Kanda Y; Shoji N; Ogasawara T; Murakami J; Tanosaki R; Tobinai K; Takaue Y; Mineishi S
    Am J Hematol; 2001 Jul; 67(3):206-9. PubMed ID: 11391721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
    Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.
    Kotecha RS; Buckland A; Phillips MB; Cole CH; Gottardo NG
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):76-80. PubMed ID: 24276042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Cases of Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Thioguanine Treatment for Acute Lymphoblastic Leukemia.
    Gruhn B; Brodt G; Mentzel HJ; Ernst J
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e572-e575. PubMed ID: 33885036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature.
    Cheng C; Dores GM; Nayernama A; Jones SC; Rabik CA
    Pediatr Hematol Oncol; 2024 Oct; 41(7):519-529. PubMed ID: 39194183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia.
    Ray M; Marwaha RK; Trehan A
    Indian J Pediatr; 2002 Feb; 69(2):185-7. PubMed ID: 11929036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.